Wealth Enhancement Advisory Services LLC lifted its position in HCA Healthcare Inc (NYSE:HCA) by 3.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 13,171 shares of the company’s stock after purchasing an additional 500 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in HCA Healthcare were worth $1,925,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its position in HCA Healthcare by 3.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 544,838 shares of the company’s stock worth $67,797,000 after acquiring an additional 16,992 shares during the last quarter. Geode Capital Management LLC raised its stake in HCA Healthcare by 10.0% during the fourth quarter. Geode Capital Management LLC now owns 3,414,676 shares of the company’s stock worth $424,189,000 after purchasing an additional 310,086 shares during the period. Valeo Financial Advisors LLC purchased a new position in HCA Healthcare during the first quarter worth approximately $66,000. First Manhattan Co. raised its stake in HCA Healthcare by 20.2% during the first quarter. First Manhattan Co. now owns 1,310 shares of the company’s stock worth $170,000 after purchasing an additional 220 shares during the period. Finally, Nisa Investment Advisors LLC raised its stake in HCA Healthcare by 9.0% during the first quarter. Nisa Investment Advisors LLC now owns 53,145 shares of the company’s stock worth $6,929,000 after purchasing an additional 4,388 shares during the period. 70.23% of the stock is currently owned by institutional investors and hedge funds.
HCA has been the topic of a number of recent analyst reports. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Barclays cut their price target on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. Stephens set a $150.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Deutsche Bank increased their price target on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Finally, Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $153.35.
HCA traded up $0.40 during trading hours on Thursday, reaching $123.67. 36,359 shares of the stock traded hands, compared to its average volume of 1,891,027. The business’s fifty day moving average price is $135.43. The firm has a market cap of $42.90 billion, a P/E ratio of 12.64, a price-to-earnings-growth ratio of 1.08 and a beta of 0.85. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). The firm had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. HCA Healthcare’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.29 earnings per share. On average, research analysts predict that HCA Healthcare Inc will post 10.35 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date is Friday, August 30th. HCA Healthcare’s payout ratio is 16.38%.
In other HCA Healthcare news, SVP Robert A. Waterman sold 33,786 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the transaction, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Patricia F. Elcan acquired 250 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were bought at an average cost of $124.10 per share, with a total value of $31,025.00. The disclosure for this purchase can be found here. 2.70% of the stock is currently owned by company insiders.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: What are the disadvantages of after-hours trading?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.